Content about Massachusetts General Hospital

March 3, 2014

An international team led by researchers at the Broad Institute and Massachusetts General Hospital has identified mutations in a gene that can reduce the risk of developing Type 2 diabetes, even in people who have such risk factors as obesity and old age, the group announced Sunday.

CAMBRIDGE, Mass. — An international team led by researchers at the Broad Institute and Massachusetts General Hospital has identified mutations in a gene that can reduce the risk of developing Type 2 diabetes, even in people who have such risk factors as obesity and old age, the group announced Sunday. The results focus the search for developing novel therapeutic strategies for Type 2 diabetes — if a drug can be developed that mimics the protective effect of these mutations, it could open up new ways of preventing this devastating disease.

January 24, 2014

Researchers from Massachusetts Eye and Ear, Harvard Medical School, Massachusetts Institute of Technology and Massachusetts General Hospital have demonstrated that aspirin intake correlates with halted growth of vestibular schwannomas, also known as acoustic neuromas, a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus.

BOSTON — Researchers from Massachusetts Eye and Ear, Harvard Medical School, Massachusetts Institute of Technology and Massachusetts General Hospital have demonstrated that aspirin intake correlates with halted growth of vestibular schwannomas, also known as acoustic neuromas, a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus.

January 15, 2013

While replacing a single combination pill for HIV with generics would save the healthcare system money, it could also diminish the effectiveness of treatment, a new study suggests.

NEW YORK — While replacing a single combination pill for HIV with generics would save the healthcare system money, it could also diminish the effectiveness of treatment, a new study suggests.

The study, led by investigators at the Massachusetts General Hospital and Weill Cornell Medical College, and published in the Jan. 15 issue of Annals of Internal Medicine, found $1 billion in potential savings, but the more complicated treatment regimen might result in more patients missing doses and a loss of drug effectiveness.

October 9, 2012

A drug maker and a hospital have entered an agreement aimed at developing new treatments for various types of hematological malignancies and solid tumors.

CAMBRIDGE, Mass. — A drug maker and a hospital have entered an agreement aimed at developing new treatments for various types of hematological malignancies and solid tumors.

Sanofi and Massachusetts General Hospital said their project-based collaboration unites scientists from the respective parties, with the goal of "maximizing the strengths of both academic and industry cross-organizational expertise, and will include both preclinical and clinical translational research to elucidate questions from proof-of-concept to tolerability, efficacy and effectiveness."

March 21, 2012

Taking vitamin E supplements does not increase or decrease heart failure risk among women, according to a study in Circulation: Heart Failure, an American Heart Association journal, released Tuesday.

DALLAS — Taking vitamin E supplements does not increase or decrease heart failure risk among women, according to a study in Circulation: Heart Failure, an American Heart Association journal, released Tuesday.

February 22, 2012

It seems insulin production and beta cell functioning may persist despite the onset of Type 1 diabetes, according to research conducted at the Massachusetts General Hospital and published in the March issue of Diabetes Care.

BOSTON — It seems insulin production and beta cell functioning may persist despite the onset of Type 1 diabetes, according to research conducted at the Massachusetts General Hospital and published in the March issue of Diabetes Care.

August 30, 2010

A new study conducted by investigators at Harvard Medical School and Massachusetts General Hospital suggested...

BOSTON A new study conducted by investigators at Harvard Medical School and Massachusetts General Hospital suggested that the dietary supplement S-adenosylmethionine (SAMe) can be an effective, relatively well-tolerated, adjunctive treatment for adults with major depressive disorders who do not respond to their treatment with antidepressant medication, Pharmavite announced Tuesday.

March 24, 2010

MinuteClinic has named Nancy Gagliano as its new chief medical officer....

WOONSOCKET, R.I. MinuteClinic has named Nancy Gagliano as its new chief medical officer.

"We are thrilled to have Nancy Gagliano join us as our chief medical officer at MinuteClinic," stated Andrew Sussman, M.D., president of MinuteClinic and SVP/associate chief medical officer at CVS Caremark. "Nancy has a superb background in clinical primary care and ambulatory care leadership. She will add great insight and experience to our leadership team as we continue to provide the highest quality care to our patients."